Allyson Berent

CSO and COO at Foundation for Angelman Syndrome Therapeutics, GeneTx Biotherapeutics

Agenda Sessions

• Leveraging platform approaches to gene therapies to accelerate therapeutic development for monogenic diseases

  On Demand

  View Session

Speakers at this event